Article
New Orleans-The AquaLase liquefaction device (Alcon) is a new technology for lens removal that provides the advantages of excellent safety for the cornea and posterior capsule without sacrificing efficiency, said Stephen F. Brint, MD.
Playing matchmaker with Schlemm canal surgery
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Multidisciplinary team secures multimillion-dollar award to fund research to achieve a functional human eye transplant
(EyePod) From idea to impact: Navigating ophthalmic innovation
Mazava Project shines light on blindness in Madagascar
Study explores the true costs of treating pediatric cataracts